Wedbush Reiterates Outperform Rating for Xencor (NASDAQ:XNCR)
Wedbush restated their outperform rating on shares of Xencor (NASDAQ:XNCR – Free Report) in a report published on Wednesday,RTT News reports. Wedbush currently has a $31.00 price target on the biopharmaceutical company’s stock. XNCR has been the subject of a number of other research reports. Wells Fargo & Company decreased their price objective on Xencor […]
Wedbush restated their outperform rating on shares of Xencor (NASDAQ:XNCR – Free Report) in a report published on Wednesday,RTT News reports. Wedbush currently has a $31.00 price target on the biopharmaceutical company’s stock. XNCR has been the subject of a number of other research reports. Wells Fargo & Company decreased their price objective on Xencor […]
